Epigenetic suppression of Nrf2–Slc40a1 axis induces ferroptosis and enhances immunotherapy in pancreatic cancer
Yixuan Zhang(Nanjing Drum Tower Hospital), Shu Zhang(Nanjing University of Chinese Medicine), Yao Fu(Illumina (United States)), Dijun Chen(Chinese Academy of Sciences), Tianqi Xu(Nanjing University), Xinjie Shen(Nanjing University), Jiajun Zhang(Shanghai Astronomical Observatory), Yin Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Qi Li(Shanxi Medical University), Lei Wang(Nanjing University), Shijin Xu(Nanjing University of Chinese Medicine), Ranran Yu(Nanjing University), Xiaoping Zou(Nanjing Drum Tower Hospital), Ziying Zhang(Nanjing University of Chinese Medicine), Ying Lv(First Affiliated Hospital of University of South China), Jiatong Tang(Nanjing University), Shiyi Song(First Affiliated Hospital of Xinxiang Medical University), Jiawei Liang(Nanjing Drum Tower Hospital), Yihan Zhao(Thermal Power Research Institute)
Cited by 7
Related Papers
Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic Cholangiocarcinoma
|New England Journal of Medicine|2023|530
Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma.
|PubMed|1994|485
Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva
|Gynecologic Oncology|1990|430